M2 MΦs induce tumour progression by driving tumour proliferation directly or indirectly by dampening T-cell functions through the secretion of cytokines and factors such as TGF-β, IL-10, IL-4, vascular epidermal growth factor (VEGF) and matrix metalloproteases (MMPs). Here, VEGFA is linked to neoplasm.